Appili Therapeutics Inc.
APLI.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -82.49% | -31.74% | 22.02% | 119.41% | -234.46% |
| Total Depreciation and Amortization | -100.00% | 14.29% | 4.00% | -12.00% | 16.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -70.44% | -123.29% | -87.51% | 353.27% | 1,107.61% |
| Change in Net Operating Assets | 148.81% | -55.16% | 1,130.30% | -143.33% | -346.15% |
| Cash from Operations | 36.49% | -283.83% | 95.23% | 312.75% | -269.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -100.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 97.83% | -13.16% | 31.54% | -77.47% | 1.78% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -110.77% | -190.18% | 30.85% | 37.16% | 26.97% |
| Cash from Financing | 469.66% | -78.41% | -112.37% | -11.81% | 13.95% |
| Foreign Exchange rate Adjustments | -221.21% | 14,733.33% | -13,233.33% | 6,971.43% | 3,400.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 71.51% | -311.28% | -149.37% | 292.55% | -324.69% |